PDS Biotechnology Corp PDSB

Recent filings and events

• 2026-09-04 Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
• 2026-09-04 New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
• 2026-08-25 Restructuring or exit costs A restructuring: layoffs, a plant closure, a business being wound down. Item 2.05
• 2026-08-25 Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
• 2026-08-19 Officer or director change Item 5.02
• 2026-08-14 Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
• 2026-08-14 Shareholder vote The results of the annual meeting or a special vote. Item 5.07
• 2026-08-13 Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
• 2026-08-11 Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
• 2026-07-31 Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
• 2026-06-15 Material agreement signed Item 1.01
• 2026-06-15 Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.